EA
MDT icon

Evolution Advisers’s Medtronic MDT Stock Holding History

Evolution Advisers’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10
Closed -$1K – 183
2024
Q1 		$1K Hold
10
– – ﹤0.01% 171
2023
Q4 		$1K Buy
+10
New +$762 ﹤0.01% 207
2023
Q3 		– Sell
-10
Closed – – 154
2023
Q2 		$0 Hold
10
– – ﹤0.01% 160
2023
Q1 		$0 Hold
10
– – ﹤0.01% 153
2022
Q4 		$0 Hold
10
– – ﹤0.01% 152
2022
Q3 		$0 Hold
10
– – ﹤0.01% 146
2022
Q2 		$0 Hold
10
– – ﹤0.01% 144
2022
Q1 		$1K Hold
10
– – ﹤0.01% 130
2021
Q4 		$1K Buy
+10
New +$1.16K ﹤0.01% 136

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Evolution Advisers's MDT Position: Q2 2024 in Review

Evolution Advisers sold out of Medtronic (MDT) in Q2 2024, closing a stake of 10 shares — an estimated $1K sold.

Evolution Advisers first reported a position in MDT in Q4 2021 and held it in 9 quarters. The position peaked at $1K in Q1 2024. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • Evolution Advisers reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
  • Evolution Advisers sold 10 Medtronic shares in Q2 2024, an estimated $1K.
  • Evolution Advisers first reported a position in Medtronic in Q4 2021 and held it in 9 quarters.
  • Evolution Advisers's Medtronic position peaked at $1K in Q1 2024.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on Evolution Advisers's 13F filing for Q2 2024, filed 26 Jul 2024.